866-997-4948(US-Canada Toll Free)

Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015

Published By :

GlobalData

Published Date : May 2015

Category :

Clinical Trials

No. of Pages : 62 Pages


GlobalData's clinical trial report, “Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015"" provides data on the Shigella Infections (Shigellosis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Shigella Infections (Shigellosis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Shigella Infections (Shigellosis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Shigella Infections (Shigellosis) 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Shigella Infections (Shigellosis) to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Unaccomplished Trials of Shigella Infections (Shigellosis) 19
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Shigella Infections (Shigellosis) Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
GlaxoSmithKline plc 26
Clinical Trial Overview of GlaxoSmithKline plc 26
Novartis AG 27
Clinical Trial Overview of Novartis AG 27
Icddr,b 28
Clinical Trial Overview of Icddr,b 28
Clinical Trial Overview of Top Institutes / Government 29
Eunice Kennedy Shriver National Institute of Child Health and Human Development 29
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 29
University of Maryland 30
Clinical Trial Overview of University of Maryland 30
Institut Pasteur 31
Clinical Trial Overview of Institut Pasteur 31
PATH 32
Clinical Trial Overview of PATH 32
U.S. Army Medical Research and Materiel Command 33
Clinical Trial Overview of U.S. Army Medical Research and Materiel Command 33
U.S. Department of Defense 34
Clinical Trial Overview of U.S. Department of Defense 34
University of Maryland, Baltimore 35
Clinical Trial Overview of University of Maryland, Baltimore 35
University of Oxford 36
Clinical Trial Overview of University of Oxford 36
Five Key Clinical Profiles 37

Appendix 60
Abbreviations 60
Definitions 60
Research Methodology 61
Secondary Research 61
About GlobalData 62
Contact Us 62
Disclaimer 62
Source 62

List of Table


Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Region, 2015* 6
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Europe, Top Countries, 2015* 10
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Proportion of Shigella Infections (Shigellosis) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 13
Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Shigella Infections (Shigellosis) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 19
Shigella Infections (Shigellosis) Therapeutics, Global, Terminated Clinical Trials, 2015* 20
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21
Shigella Infections (Shigellosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 26
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 27
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Icddr,b, 2015* 28
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 29
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, 2015* 30
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Pasteur, 2015* 31
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by PATH, 2015* 32
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Research and Materiel Command, 2015* 33
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Defense, 2015* 34
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, Baltimore, 2015* 35
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2015* 36

List of Chart


Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 10
Proportion of Shigella Infections (Shigellosis) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 13
Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21
Shigella Infections (Shigellosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
GlobalData Methodology 61

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *